Lorvotuzumab Antibody
Lorvotuzumab is a humanized monoclonal antibody targeting CD56 (NCAM1) . It serves as the antibody component for the antibody-drug conjugate lorvotuzumab mertansine, utilized in research applications for studying CD56-positive cancers in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
ADCAntibody, ADC Antibody
Target
ADC Antibody
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
4.66 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
146.44 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
